Latest filing published 01 Dec 2025 for UroGen Pharma Ltd.. Read the official filing
Cynthia M. Butitta is a declared insider at 3 companies; the most frequent names are Kite Pharma, Inc., Olema Pharmaceuticals, Inc. and UroGen Pharma Ltd. The record holds 70 filings, for trades running from 27 January 2016 to 26 November 2025.
No open-market purchase appears, only 48 sales worth €14.3M. Outside the open market, there are 2 share grants and 18 option exercises.
On 1 December 2025 came the latest disclosure, an option exercise in UroGen Pharma Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 70 declarations